Colinz Laboratories Ltd
₹0.00▲ +0.00 (+0.00%)
531210·NSE·Healthcare
Market Cap
10.16 Cr
PE Ratio
19.70
Volume
—
Day High - Low
—
52W High-Low
87.91 - 36.11
₹0.00▲ +0.00 (+0.00%)
Market Cap10.16 Cr
PE Ratio19.70
Volume—
Day High - Low—
52W High-Low87.91 - 36.11
Colinz Laboratories Ltd (531210): company summary
Colinz Laboratories Ltd (531210) is a micro-cap Healthcare company valued at ₹10 crore operating in Pharmaceuticals on the NSE and BSE.
Colinz Laboratories Ltd (531210) is a micro-cap Healthcare company valued at ₹10 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -5.0% a year over three years; profit grew 4.2% a year, ahead of revenue — margins are expanding. Return on equity is 5.2%.
- Valuation multiples
- The stock trades at 19.7 times earnings, a discount to the Healthcare median of 32.5, 1.15 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
5.23%
Weak
P/E
19.70x
Fair
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Weak
Price performance
52W₹36.11
₹87.91
DocStoX take
Supported by growth (6.1), but held back by quality (2.5). Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.5
/10
Weak
Quality
Weak
ROE 5.2%
Valuation
Rich
P/E 19.7×
Growth
Steady
Revenue -0.1% 5Y CAGR
Risk
Moderate
D/E 0.04
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹10 Cr
52W High / Low
₹88 / ₹36
Dividend Yield
0.00%
Promoter Holding
50.60%
EPS (TTM)
₹1.98
Book Value
₹69.70
Key highlights
- Low leverage — D/E 0.04
- Profitable in all of the last 5 years
- Profit compounding 20% a year
- Revenue shrinking 0% a year
- Small ₹10 cr company — thinner liquidity
3 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Colinz Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Colinz Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Colinz Laboratories Ltd with peers
Related tools & concepts
Value Colinz Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing